Avaliação do tratamento de depressão em pacientes com doença de Parkinson através de ressonância magnética funcional / Evaluation of depression treatment in Parkinsons disease patients with functional magnetic resonance

AUTOR(ES)

Ellison Fernando Cardoso

DATA DE PUBLICAÇÃO

2008

RESUMO

The neural circuitry underlying depression in patients with Parkinsons disease (PD) is unknown, let alone the treatment effects of antidepressant therapy. Neuroimaging methods can give insights into the pathogenesis of depression and also in the mechanisms of action related to specific treatment choice. In order to evaluate differences between PD patients with and without concomitant depression we studied 21 patients with PD and depression and 16 PD patients without depression using fMRI. All patients were examined using an event-related fMRI paradigm based on visual presentation of faces with emotional content in a two options forced choice task. Furthermore the twenty-one PD depressed patients were randomized in two active treatment groups for 4 weeks: active rTMS over left dorsolateral prefrontal cortex (5 Hz rTMS - 120% motor threshold) with placebo pill and sham rTMS with fluoxetine 20 mg/day. Event-related fMRI with emotional stimuli was performed before and after treatment - in two sessions (test and re-test) at each time point. The same test-retest approach was adopted in the group of non-depressed PD patients. The analysis showed significant differences between depressed and non-depressed PD patients in the medial pre-frontal cortex, with reduced activation as detected by BOLD effect in the later group. The two groups of depressed PD patients showed a had a significant treatment effect, and with similar mood improvement. After rTMS treatment, there were brain activity decreases in left fusiform gyrus, cerebellum and right dorsolateral prefrontal cortex (DLPFC) and brain activity increases in left DLPFC and anterior cingulate gyrus as compared to baseline. In contrast, after fluoxetine treatment, there was brain activity increases in right premotor and right medial prefrontal cortex. There was a significant interaction effect between groups versus time in the left medial prefrontal cortex, suggesting that the activity in this area changed differently in the two treatment groups. Our findings show that medial prefrontal cortex is a critical area in the depression neural circuitry in PD. Antidepressant effects of rTMS and fluoxetine in PD are associated with changes in different areas of the depression-related neural network.

ASSUNTO(S)

depression/therapy depressão/terapia transcranial magnetic stimulation doença de parkinson estimulação magnética transcraniana parkinson disease magnetic resonance imaging fluoxetina imagem por ressonância magnética fluoxetine

Documentos Relacionados

• Avaliação do tratamento de depressão em pacientes com doença de Parkinson através de ressonância magnética funcional
• Word generation in Parkinsons disease a functional magnetic resonance study
• Magnetic resonance anatomic and functional study of juvenile myoclonic epilepsy patients.
• Ressonância magnética funcional para avaliação do incômodo do zumbido em pacientes com audiometria normal
• Vestibular function evaluation by subjective visual vertical in patients with Parkinsons disease